Core Viewpoint - The company ST Pava is focusing on the development of sodium battery precursors and solid-state battery materials, with significant increases in R&D investment and production capacity expected in the coming years [2][3][4]. Group 1: R&D Focus and Investment - The company plans to increase R&D expenses significantly in 2024, with a total investment of 83.94 million yuan, representing a year-on-year increase of 65.34% [3]. - Key areas of R&D include solid electrolyte materials, lithium battery high-voltage precursor materials, and sodium copper-based multi-element precursor materials [3]. - The company has applied for 18 invention patents in solid-state battery materials and collaborates with a professor team from Central South University for product development [4]. Group 2: Market Outlook and Production Capacity - The company is optimistic about the sodium battery industry's development, particularly in energy storage, two-wheeled vehicles, small power, engineering machinery, and heavy-duty vehicle battery swapping [4]. - Current production capacity for sodium battery precursors is 7,500 tons, with the ability to quickly switch production lines to meet increasing demand [4]. - The company anticipates that the cost of sodium battery cells will align with that of lithium iron phosphate cells this year and be on par next year, potentially leading to a cost advantage in the future [4]. Group 3: Governance and Operational Challenges - The company acknowledges challenges in market competition and aims to enhance operational efficiency and governance structures to improve profitability [5]. - The company is undergoing corrective measures due to a negative audit opinion on its internal controls for the 2024 financial report, including forming a special team to address deficiencies [6]. - The overall operational goal is to reduce costs and improve efficiency, with a focus on optimizing business structure and enhancing internal controls [6].

Core Viewpoint - Zhejiang Pawa New Energy Co., Ltd. is holding a shareholders' meeting to discuss various proposals, including changes to registered capital and amendments to the company's articles of association, in light of recent financial performance and governance requirements [1][13]. Meeting Procedures - All attendees must respect the rights of shareholders and maintain order during the meeting, with specific rules for participation and voting outlined [2][3]. - Only authorized personnel, including shareholders, directors, and invited guests, are allowed to enter the meeting venue [2]. - Attendees must register and verify their identity before participating in the voting process, which will combine both on-site and online voting methods [3][4]. Financial Performance - For the fiscal year 2024, the company reported a net loss attributable to shareholders of approximately -726.5 million yuan, a decline of 193.37% year-on-year [17]. - Total assets as of December 31, 2024, were approximately 2.89 billion yuan, down 26.36% from the beginning of the year [17]. - The company plans to address its financial challenges by optimizing its business structure, enhancing cost control, and improving supply chain management [11][12]. Proposals for Shareholder Approval - The board has proposed several key resolutions for shareholder approval, including: - The 2024 annual financial report and its summary [8]. - A proposal for profit distribution, indicating no cash dividends due to negative retained earnings [9]. - A plan for the 2025 director and supervisor remuneration [9][10]. - A proposal to amend the articles of association following a reduction in registered capital due to share buybacks [13][14]. Governance and Compliance - The company emphasizes adherence to legal and regulatory requirements, ensuring that all board and shareholder meetings are conducted in compliance with relevant laws [20][21]. - The board and supervisory committee have been active in monitoring the company's operations and financial reporting, ensuring transparency and accountability [22][29]. Future Outlook - The company aims to enhance its operational efficiency and profitability through strategic initiatives, including technological innovation and market responsiveness [11][12]. - Plans for 2025 include strengthening investor relations and improving communication with stakeholders to bolster confidence in the company's governance and performance [24][23].

2024 年年度股东大会会议资料 证券代码：688184 证券简称：ST 帕瓦 浙江帕瓦新能源股份有限公司 2024 年年度股东大会会议资料 2025 年 5 月 1 2024 年年度股东大会会议资料 目录 | 2024 | | 年年度股东大会会议须知 | 3 | | --- | --- | --- | --- | | 2024 | | 年年度股东大会会议议程 | 5 | | 2024 | | 年年度股东大会会议议案 | 7 | | 关于 | 2024 | 年度董事会工作报告的议案 | 7 | | 关于 | 2024 | 年度监事会工作报告的议案 | 8 | | 关于 | 2024 | 年度独立董事述职报告的议案 | 9 | | 关于 | 2024 | 年度财务决算报告的议案 | 10 | | 关于 | 2024 | 年年度报告及其摘要的议案 | 11 | | 关于 | 2024 | 年度利润分配预案的议案 | 12 | | 关于 | 2025 | 年度董事薪酬方案的议案 | 13 | | 关于 | 2025 | 年度监事薪酬方案的议案 | 14 | | | | 关于未弥补亏损达实收股本总额三分之一的议案 | ...

Core Viewpoint - The article highlights the financial struggles of four ST companies listed on the Sci-Tech Innovation Board, all of which experienced significant declines in net profit after their initial public offerings (IPOs) [1] Group 1: Company Overview - As of May 9, there are 586 companies listed on the Sci-Tech Innovation Board, with four classified as ST companies: ST Pava, *ST Guandian, *ST Tianwei, and ST Yifei [1] - All four companies had the highest net profit in the year of their IPO, followed by substantial declines or direct losses in the subsequent year [1] Group 2: ST Pava - ST Pava was listed on September 19, 2022, with a focus on the research, production, and sales of new energy battery materials [2][3] - The company reported revenues of 1.65626 billion yuan in 2022, which dropped to 954.27 million yuan in 2023 and further to 948.57 million yuan in 2024 [3] - The net profit figures were 108.56 million yuan in 2022, -250.03 million yuan in 2023, and -731.76 million yuan in 2024 [3] - The stock was placed under risk warning due to a negative internal control audit opinion from its auditing firm [4] Group 3: *ST Guandian - *ST Guandian transitioned to the Sci-Tech Innovation Board on May 25, 2022, specializing in drone flight services and defense equipment [6] - The company achieved revenues of 291.04 million yuan in 2022, which fell to 212.10 million yuan in 2023 and further declined to 89.98 million yuan in 2024 [7] - The net profit figures were 78.69 million yuan in 2022, 13.26 million yuan in 2023, and -111.15 million yuan in 2024 [7] - The stock was flagged for delisting risk due to negative profit figures and low revenue [8] Group 4: *ST Tianwei - *ST Tianwei was listed on July 30, 2021, focusing on fire suppression systems and related products [9] - The company reported revenues of 205.82 million yuan in 2021, which decreased to 110.75 million yuan in 2022, then increased to 140.48 million yuan in 2023, and dropped to 77.75 million yuan in 2024 [10] - The net profit figures were 114.54 million yuan in 2021, 44.92 million yuan in 2022, 49.70 million yuan in 2023, and -29.16 million yuan in 2024 [10] - The stock was placed under risk warning due to negative profit and revenue figures [11] Group 5: ST Yifei - ST Yifei was listed on July 28, 2023, focusing on precision laser processing equipment [12] - The company achieved revenues of 538.96 million yuan in 2022, 697.2 million yuan in 2023, and 692.1 million yuan in 2024 [13] - The net profit figures were 68.10 million yuan in 2022, 75.75 million yuan in 2023, and 9.41 million yuan in 2024 [13] - The stock was flagged for risk due to negative audit opinions from its auditing firm [13]

瑞财经 严明会5月6日，上市不足三年的帕瓦股份（688184.SH）被实施其他风险警示，更名为"ST帕瓦"，开盘即跌停，审计机构对2024年财 报内控出具否定意见。 回顾其财报，2023年，帕瓦股份营收骤降29%，净利润亏损9737万元；2024年亏损进一步扩大至10.97亿元。而上市前，公司2020-2022年营收 年增速超48%，归母净利润年增长超74%。 1997年5月至2007年9月，张宝历任中南大学助教、讲师；2007年9月，任中南大学冶金科学与工程学院副研究员；2010年12月，任韩国 KIGAM研究院访问学者；2009年7月，历任中南大学校团委书记、冶金与环境学院党委书记；2012年9月至今，任中南大学冶金与环境学院研 究员、博士生导师；2023年1月至2024年4月，任帕瓦供应链管理有限公司执行董事、总经理；2018年7月至今，任公司董事、总经理，2022 年10月至今，任公司董事长。 帕瓦股份董事长兼总经理为张宝，中南大学冶金物理化学博士、化学工程与技术博士后。 东方财富数据显示，2020年至2024年，张宝的薪酬分别为120.7万元、243.2万元、268.8万元、297.8万元、120. ...

Core Viewpoint - The financial performance of Pava Co. in 2024 is concerning, with significant losses and internal control issues leading to a downgrade in stock status to ST Pava [1][4][6] Financial Performance - Total revenue for 2024 was 949 million, a slight decrease of 0.60% year-on-year - Gross profit was -181 million, with net profit attributable to shareholders and net profit excluding non-recurring items at -727 million and -732 million, representing year-on-year declines of 193.37% and 192.68% respectively [1][4] - Compared to 2023, the net profit attributable to shareholders and net profit excluding non-recurring items were -248 million and -250 million, showing declines of 269.86% and 330.31% respectively [4] - Rolling quarter-on-quarter growth rates for 2024 showed declines of -26.26% for total revenue, -40.47% for net profit attributable to shareholders, and -41.72% for net profit excluding non-recurring items, indicating worsening financial conditions [4] Industry Background - The lithium battery industry experienced robust growth in 2024, driven by the booming electric vehicle and energy storage markets - Global lithium-ion battery shipments reached 1,545.1 GWh, a year-on-year increase of 28.5%, with China accounting for 1,214.6 GWh, up 36.9% [4] - Despite the industry's growth, Pava Co. failed to capitalize on these opportunities, facing intense competition and market challenges [5] Internal Control Issues - The major issue in Pava Co.'s 2024 annual report was the negative opinion on internal controls issued by Tianjian Accounting Firm, leading to the stock being flagged for risk and renamed ST Pava [6] - In the 2025 Q1 report, the company disclosed issues with financial data, including inflated revenue and underreported inventory impairment, highlighting serious deficiencies in financial management [6]

Core Viewpoint - The recent financial report of Pava Co., Ltd. (688184) for Q1 2025 indicates a significant decline in revenue and persistent negative net profit, raising concerns about cash flow and expense management [1][6]. Financial Overview - As of the end of the reporting period, the total operating revenue was 80.01 million yuan, a year-on-year decrease of 72.59% [2][3]. - The net profit attributable to shareholders was -56.01 million yuan, an increase of 46.01% year-on-year [2][3]. - The net profit excluding non-recurring items was -59.69 million yuan, up 42.46% year-on-year [2][3]. Quarterly Data - In Q1 2025, the total operating revenue was 80.01 million yuan, reflecting a 72.59% year-on-year decline [3]. - The net profit attributable to shareholders was -56.01 million yuan, which is a 46.01% increase compared to the previous year [3]. - The net profit excluding non-recurring items was -59.69 million yuan, showing a 42.46% year-on-year increase [3]. Expense Ratio - The proportion of three major expenses (financial, sales, and management expenses) significantly increased, with a total of 13.87 million yuan, accounting for 17.34% of total revenue, which is a 411.08% year-on-year increase [4]. Key Financial Indicators - Gross margin was 79.33%, a year-on-year increase of 2360.9% [5]. - Net margin was -70.0%, a decrease of 96.99% year-on-year [5]. - Earnings per share was -0.34 yuan, an increase of 90.88% year-on-year [5]. - Cash flow per share was -0.74 yuan, a decrease of 6.01% year-on-year [5]. - The company had monetary funds of 393 million yuan, an increase of 46.48% year-on-year [5]. - Accounts receivable amounted to 60.28 million yuan, a decrease of 82.66% year-on-year [5]. - Interest-bearing liabilities were 179 million yuan, an increase of 1040.88% year-on-year [5]. Business Model and Financing - The company's performance is primarily driven by R&D and capital expenditures, with a total financing amount of 1.743 billion yuan since its listing and total dividends of 44.34 million yuan, resulting in a dividend-to-financing ratio of 0.03 [5]. Issues to Monitor - The ratio of monetary funds to current liabilities is only 60.86%, and the average cash flow from operating activities over the past three years has been negative, indicating a need for attention to cash flow conditions [6]. - The financial expenses situation has also been concerning, with the average net cash flow from operating activities over the past three years being negative [6].

4月29日，帕瓦股份（维权）（SH688184，停牌，市值17.62亿元）发布2024年年度报告。 《每日经济新闻》记者注意到，年度审计机构天健会计师事务所（特殊普通合伙）（以下简称天健所）对帕瓦股份2024年财务报告出具了保留意见的审计报 告。 天健所表示，帕瓦股份存在与供应商交易价格不公允的情形，累计向部分供应商多支付工程及设备款1.8亿元。 帕瓦股份公司实际控制人张宝出具承诺，将对相关供应商未归还的多付工程及设备款承担连带赔偿责任。 每经记者 赵李南 每经编辑 魏官红 图片来源：由每经财报智能体一键生成 2024年，帕瓦股份归属于上市公司股东的净利润约-7亿元。天健所对其财务报告出具了保留意见的审计报告。 据帕瓦股份2024年年报，其经过自查确认，公司2023年度存在与供应商交易价格不公允的情形，累计向部分供应商多付工程及设备款1.8亿元。截至公司财 务报表批准对外报出日，相关供应商尚未归还上述多付的工程及设备款。 "公司对自查发现的上述问题采用追溯重述法进行了更正。公司实际控制人张宝出具承诺，将对相关供应商未归还的多付工程及设备款承担连带赔偿责 任。"帕瓦股份表示。 对于上述多付1.8亿元事项，天健所 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 2025年4月30日，帕瓦股份（维权）因内控被否触发"其他风险警示"，更名为"ST帕瓦"，成为科创板首 例因内控问题"戴帽"的企业。 事实上，我们在今年2月对该公司风险提前发出预警。在《帕瓦股份审计程序不到位暴露两大风险？存 货减值计提是否充分 收入端是否存水分》一文，我们对公司收入真实性及资产是否可能高估发出质 疑。 警示函揭开财务舞弊链条：系统性造假与审计失守 2025年3月26日，浙江证监局的一纸《警示函》揭开帕瓦股份（688184.SH）财务舞弊的冰山。监管调 查显示，该公司通过虚增营业收入、少提存货跌价准备、虚增在建工程等系统性手段，导致2023年年报 及2024年多期定期报告存在重大错报。具体而言： 收入端造假：虚构交易与会计处理弹性 现金流恶化与监管连环问责 公司经营质量持续恶化：2023年经营活动现金流净额同比下滑133.7%，2024年上半年进一步录得-1.14 亿元。浙江证监局在一年内两次下发警示函，直指其业绩预告差异超1.1亿元、多期财报信息披露失 真。审计机构容诚所更因"工作量远超预期"火速辞任，侧面印证财务数据存在重大审计障碍。 这一 ...

Financial Performance - In Q1 2025, the company reported revenue of 0.80 billion yuan, a decrease of 72.59% year-on-year [1][2] - The net profit attributable to shareholders was -0.56 billion yuan, compared to -1.04 billion yuan in the same period last year [1][2] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -0.60 billion yuan, unchanged from the previous year [1][2] - The net cash flow from operating activities was -1.18 billion yuan, slightly worse than -1.12 billion yuan in the same period last year [1][4] Annual Report Insights - For the year 2024, the company achieved revenue of 9.49 billion yuan, a slight decline of 0.60% year-on-year [4][5] - The net profit attributable to shareholders for 2024 was -7.27 billion yuan, compared to -2.48 billion yuan in 2023 [4][5] - The net cash flow from operating activities for 2024 was -5.06 billion yuan, a significant drop from 1.48 billion yuan in 2023 [4][6] Audit and Compliance Issues - The company received a negative audit opinion from Tianjian Accounting Firm regarding its 2024 financial report, leading to a risk warning for its stock [7][8] - The company acknowledged management issues, resulting in overpayments to suppliers totaling 180 million yuan, with the chairman committing to recover these funds [7] - The stock will be suspended from trading starting April 30, 2025, and will resume trading with a risk warning on May 6, 2025 [8] Stock Market Performance - The company was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on September 19, 2022, with an initial public offering price of 51.88 yuan per share [8] - The stock reached a peak price of 45.92 yuan on its first trading day but has since been in a downward trend, currently trading below its IPO price [8] - The total funds raised from the IPO amounted to approximately 1.74 billion yuan, exceeding the planned amount by 85.75 million yuan [8][9]